Clinical studies recruiting near Toronto

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

THC Titration of High-Potency Cannabis Concentrates
NA · Centre for Addiction and Mental Health · Centre for Addiction and Mental Health · NCT07105449 A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC
NA · University Health Network - Princess Margaret Cancer Centre · University Health Network, Toronto · NCT07628751 Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy
Phase N/A · Mount Sinai Hospital · Mount Sinai Hospital, Canada · NCT05708105 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-11008, Toronto, ON · Colorado Prevention Center · NCT06024746 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Sunnybrook Health Sciences Center · Joseph Broderick, MD · NCT07227246 Oropharyngeal Exercises to Treat Obstructive Sleep Apnea
NA · Sunnybrook Health Sciences Centre · Sunnybrook Health Sciences Centre · NCT05678088 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
Phase 2 · University Health Network · University Health Network, Toronto · NCT06216470 Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · The Hospital for Sick Children · Arkansas Children's Hospital Research Institute · NCT03827694 Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodro
Phase 2 · Toronto Western Hospital · Michael J. Fox Foundation for Parkinson's Research · NCT07265596 Clinical Study of the inQB8 TTVR System (The MonarQ Study)
NA · St. Michael's Hospital · inQB8 Medical Technologies, LLC · NCT06611579 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Princess Margaret Cancer Centre · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · North York General Hospital ( Site 0415) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Odette Cancer Centre- Sunnybrook Health Sciences Centre · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Hospital for Sick Children · National Cancer Institute (NCI) · NCT05099003 Single-Sided Deafness and Asymmetric Hearing Loss
NA · Sunnybrook Health Sciences Center · Med-El Corporation · NCT04506853 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · The POLEmut-BLUE trial: Princess Margaret Cancer Centre, Uni · Leiden University Medical Center · NCT05255653 Perceptual Abnormalities and Their Malleability in BDD
NA · Centre for Addiction and Mental Health · Centre for Addiction and Mental Health · NCT04373629 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Hospital for Sick Children · National Cancer Institute (NCI) · NCT06172296 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Toronto General Hospital (TGH) · Vertex Pharmaceuticals Incorporated · NCT04786262 A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
NA · Princess Margaret Cancer Centre · University Health Network, Toronto · NCT06451445 Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Phase 2 · Centre for Addiction and Mental Health · Centre for Addiction and Mental Health · NCT06518720 Carotid Intraplaque Neovascularization Combined With Stress Echo
Phase N/A · Unity Health Toronto · Dr. Amer Johri · NCT05416385 Spinal Cord Injury Registry - North American Clinical Trials Network
Phase N/A · University of Toronto/Toronto Western Hospital · Robert G. Grossman, MD · NCT00178724 First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07332455 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · University Health Network · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 The DRAGON 2 Trial
NA · Sunnybrook Hospital · Maastricht University · NCT05428735 Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Phase 2 · Toronto General Hospital, University Health Network · Population Health Research Institute · NCT04680442 Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children
NA · The Hospital for Sick Children · The Hospital for Sick Children · NCT06529380

Look up another city

Look up another condition